Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.

Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.

Näytä muut versiot (1)

Regulatory T cells (T(reg)) are currently being tested in clinical trials as a potential therapy in cell and solid organ transplantation. The immunosuppressive drug rapamycin has been shown to preferentially promote T(reg) expansion. Here, we hypothesized that adjunctive rapamycin therapy might pote...

Bibliografiset tiedot
Päätekijät:	Hester, J, Schiopu, A, Nadig, SN, Wood, K
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2012

Samankaltaisia teoksia

Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.
Tekijä: Hester, J, et al.
Julkaistu: (2012)

In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.
Tekijä: Nadig, SN, et al.
Julkaistu: (2010)

Inflammatory Ly-6Chi monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients
Tekijä: Schiopu, A, et al.
Julkaistu: (2012)

Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.
Tekijä: Schiopu, A, et al.
Julkaistu: (2012)

Ex vivo expanded human treg inhibit the development of transplant arteriosclerosis in a humanized in vivo model
Tekijä: Nadig, SN, et al.
Julkaistu: (2008)

Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo.
Tekijä: Warnecke, G, et al.
Julkaistu: (2007)

CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis.
Tekijä: Warnecke, G, et al.
Julkaistu: (2010)

Ly-6C(hi) monocytes: a potential target for preventing transplant arteriosclerosis?
Tekijä: Schiopu, A, et al.
Julkaistu: (2013)

Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3.
Tekijä: Ensminger, S, et al.
Julkaistu: (2008)

SELECTIVE INHIBITION OF KRAS SIGNALING BY COMBINATION OF LOW DOSE RAPAMYCIN AND PACLITAXEL IN VIVO
Tekijä: M. N. Yurova, et al.
Julkaistu: (2018-07-01)

Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.
Tekijä: Issa, F, et al.
Julkaistu: (2010)

The persistence of transplant arteriosclerosis despite CD154 blockade.
Tekijä: Billing, J, et al.
Julkaistu: (2001)

Effective Attenuation of Arteriosclerosis Following Lymphatic-Targeted Delivery of Hyaluronic Acid-Decorated Rapamycin Liposomes
Tekijä: Liu X, et al.
Julkaistu: (2023-08-01)

Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.
Tekijä: Feng, G, et al.
Julkaistu: (2011)

Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.
Tekijä: Ensminger, S, et al.
Julkaistu: (2000)

Indirect allorecognition plays a pivotal role in the pathogenesis of transplant arteriosclerosis.
Tekijä: Ensminger, S, et al.
Julkaistu: (2000)

Investigation into the onset and progression of transplant arteriosclerosis in a mice aortic retransplantation model.
Tekijä: Steger, U, et al.
Julkaistu: (2008)

Indirect allorecognition can play an important role in the development of transplant arteriosclerosis.
Tekijä: Ensminger, S, et al.
Julkaistu: (2002)

Immune-Mediated Vascular Injury and Dysfunction in Transplant Arteriosclerosis
Tekijä: Anna evon Rossum, et al.
Julkaistu: (2015-01-01)

Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.
Tekijä: Wu, D, et al.
Julkaistu: (2013)

Comparison of the effects of exposure to a single or multiple donor alloantigens in the development of transplant arteriosclerosis.
Tekijä: Ensminger, S, et al.
Julkaistu: (2001)

Regulatory immune cells in transplantation.
Tekijä: Wood, K, et al.
Julkaistu: (2012)

CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade.
Tekijä: Ensminger, S, et al.
Julkaistu: (2000)

Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts.
Tekijä: Spriewald, B, et al.
Julkaistu: (2003)

Complex arterial reconstruction for pancreas transplantation in recipients with advanced arteriosclerosis.
Tekijä: Muthusamy, A, et al.
Julkaistu: (2008)

The Severity of Obstructive Sleep Apnea Increases the Risk of Arteriosclerosis
Tekijä: Biwen Tang, et al.
Julkaistu: (2022-03-01)

Eosinophils are major effector cells for the development of transplant arteriosclerosis and depend on the presence of IL-4.
Tekijä: Ensminger, S, et al.
Julkaistu: (2000)

Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts.
Tekijä: Ensminger, S, et al.
Julkaistu: (2002)

Tadalafil attenuates graft arteriosclerosis of aortic transplant in a rat model
Tekijä: Xu Ziqiang, et al.
Julkaistu: (2015-09-01)

Transplantation tolerance: lessons from experimental rodent models.
Tekijä: Kingsley, C, et al.
Julkaistu: (2007)

Mouse endothelial CD40 expression does not play a role during the development of transplant arteriosclerosis.
Tekijä: Ensminger, S, et al.
Julkaistu: (2003)

Low-dose rapamycin does not impair vascular integrity and tubular regeneration after kidney transplantation in rats
Tekijä: Uwe Hoff, et al.
Julkaistu: (2021-08-01)

Low dose rapamycin exacerbates autoimmune experimental uveitis.
Tekijä: Zili Zhang, et al.
Julkaistu: (2012-01-01)

Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
Tekijä: Ensminger, S, et al.
Julkaistu: (2001)

C-Reactive Protein and Arteriosclerosis
Tekijä: Jan Torzewski, et al.
Julkaistu: (2014-01-01)

Helicobacter pylori infection and arteriosclerosis
Tekijä: Tamara Anna Rakszewska, et al.
Julkaistu: (2019-04-01)

Helicobacter pylori infection and arteriosclerosis
Tekijä: Tamara Anna Rakszewska, et al.
Julkaistu: (2019-04-01)

Paradoxical aspects of rapamycin immunobiology in transplantation.
Tekijä: Ferrer, I, et al.
Julkaistu: (2011)

Pharmacology in Health Food: Metabolism of Quercetin In Vivo and Its Protective Effect Against Arteriosclerosis
Tekijä: Keisuke Ishizawa, et al.
Julkaistu: (2011-01-01)

Combination Therapy With Rapamycin and Low Dose Imatinib in Pulmonary Hypertension
Tekijä: Yinan Shi, et al.
Julkaistu: (2021-11-01)